The latest Novartis action to shutdown RNAi research based on:
"... the lingering problems associated with delivering these therapies tied to the small number of relevant targets they could shoot for drove the move."
http://www.fiercebiotech.com/story/breaking-novartis-slams-brakes-rnai-development-efforts/2014-04-14
This contrasts with the EET and potential Phenomica progress in which:
- The delivery problem has been completely resolved;
- The targeting problem looks like it can be feasibly addressed; and
- The complex RNA payload against gene expression can be replaced with a simple payload against phenotype expression.
Compare the multiple billion$ directed to RNAi programmes - where Phylogica's tens of million$ actually has produced a significantly more effective platform.
- Forums
- ASX - By Stock
- slamming on the rnai brakes
The latest Novartis action to shutdown RNAi research based...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $461.9M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.8¢ | $362.4K | 3.601M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 153489 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 177837 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 18557 | 0.099 |
3 | 352320 | 0.098 |
5 | 186653 | 0.097 |
6 | 261411 | 0.096 |
6 | 134562 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 202544 | 5 |
0.105 | 538974 | 4 |
0.110 | 689617 | 11 |
0.115 | 618463 | 5 |
0.120 | 623048 | 5 |
Last trade - 14.07pm 29/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |